Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Existential Dilemma of Israeli Biotech

This article was originally published in Start Up

Executive Summary

Israel's biotech industry -- a scientific and entrepreneurial dynamo but starved for capital, infrastructure, and managerial experience -- is facing its existential dilemma. For some, the industry's current problems are merely a reflection of economic Darwinism; others are planning more radical financing innovations. Meanwhile, the relatively rich in Israel, some of the incubators like Clal, and especially the country's biggest company, Teva, are soaking up the available opportunities for relatively little money.

Related Content

BioLineRx, Israel’s Biotech Incubator, Nearing Major Inflection Points
Xenia's Public-Private Blend Fosters Early-Stage Medtech
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q3 2008
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q3 2008
Israel's Device Community: Finding New Models as Medtech Matures
Mixed Blessing: Teva and Israeli Biotech
U.S.-Israel Tussle Over IP Rights Continues; New Free Trade Policy Is Limited
Public Venture Capital for Israel's Biotech Industry


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts